18-Jan-2022 | Facts and Factors
“Blood and Blood Components Market By Product (Whole Blood, and Blood Components), By Application (Anemia, Trauma & Surgery, Cancer Treatment, and Bleeding Disorders), By Blood Components (Red Blood Cells, Platelets, Plasma, and White Blood Cells), and By End-User (Hospitals, Ambulatory Surgical Centers, and Others): Global Industry Outlook, Market Size, Business Intelligence, Consumer Preferences, Statistical Surveys, Comprehensive Analysis, Historical Developments, Current Trends, and Forecasts, 2021–2026” states that the global demand for the blood and blood components market in 2020 was approximately USD 36,000 Million. The market is expected to grow at a CAGR of 5.4% and is anticipated to reach around USD 47,000 Million by 2026.
Blood alludes to the liquid which flows in the vascular arrangement of the majority of creatures, as well as people. The red blood cells, white blood cells, platelets, and plasma are its four most important components. The blood and blood components are used in numerous medical treatments like bleeding disorders, cancer treatment, trauma and surgery, and anemia. Additionally, they are also broadly utilized in the surgery of severely traumatized patients and resuscitation applications.
The growing occurrence of trauma and road accidents is a key factor driving the global blood and blood components market. Also, the increase in the number of chronic illnesses such as cancer, liver disease among others, and its high patient pool is likely to stimulate the blood and blood components market growth. In addition, the rising incidence of bleeding disorders and the growing number of surgeries worldwide are other growth factors that are expected to fuel the market expansion. Furthermore, the significant increase in the geriatric population that is exposed to various chronic disorders such as liver cirrhosis will generate a great demand for blood derivatives during the forecast period. The rising awareness about the importance of blood donations between people along with the rising need for blood and blood derivatives in traumatic patients is also responsible for the influence of the demand for whole blood, which in turn, will boost the market growth.
On the other hand, the increase in the possibility of developing any transfusion-transmitted infection (TTI) might hamper the growth of the market.
The global blood and blood components market can be classified into five major regional segments North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa. The region of Asia-Pacific will probably witness the fastest-growing market in the global blood and blood components market during the forecast period, owing to the growth factors like the advanced healthcare infrastructure and the existence of a high number of donors in this region. Other factors that are likely to fuel the Asia-Pacific market include the encouraging government initiatives as well as numerous untapped prospects in the rising markets of India and China.
Sarstedt AG & Co., Australian Red Cross Blood Service, Haemonetics Corporation, Abbott Laboratories, Terumo Corporation, Blood Centers of America, Medtronic Plc., Becton Dickinson and Company, Macopharma, German Red Cross, Fresenius Kabi, Nipro Medical Corporation, Medimmune (AstraZeneca), American Association of Blood Banks, Grifols International SA, AVIS National, Roche Diagnostics, National Blood Authority Australia, Ortho Clinical Diagnostics, Vitalant, Novo Nordisk, Baxter International Inc., Novartis, CSL Behring, Immucor, Thermo Fisher Scientific Inc., and American Red Cross are some top companies operating in the global blood and blood components market. Moreover, key players are adopting partnerships and collaborations to expand their customer base and create awareness in the global market.
Browse the full “Blood and Blood Components Market By Product (Whole Blood, and Blood Components), By Application (Anemia, Trauma & Surgery, Cancer Treatment, and Bleeding Disorders), By Blood Components (Red Blood Cells, Platelets, Plasma, and White Blood Cells), and By End-User (Hospitals, Ambulatory Surgical Centers, and Others): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2021 – 2026” report at https://www.fnfresearch.com/blood-and-blood-components-market
This report segments the global blood and blood components market as follows:
Global Blood and Blood Components Market: By Product
- Whole Blood
- Blood Components
Global Blood and Blood Components Market: By Application
- Anemia
- Trauma & Surgery
- Cancer Treatment
- Bleeding Disorders
Global Blood and Blood Components Market: By Blood Components
- Red Blood Cells
- Platelets
- Plasma
- White Blood Cells
Global Blood and Blood Components Market: By End-User
- Hospitals
- Ambulatory Surgical Centers
- Others
Global Blood and Blood Components Market: Regional Segmentation Analysis
- North America
- Europe
- France
- The UK
- Spain
- Germany
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South Korea
- Southeast Asia
- Rest of Asia Pacific
- Latin America
- Brazil
- Mexico
- Rest of Latin America
- Middle East & Africa
- GCC
- South Africa
- Rest of Middle East & Africa
About Us:
Facts & Factors is a leading market research organization offering industry expertise and scrupulous consulting services to clients for their business development. The reports and services offered by Facts and Factors are used by prestigious academic institutions, start-ups, and companies globally to measure and understand the changing international and regional business backgrounds. Our client’s/customer’s conviction on our solutions and services has pushed us in delivering always the best. Our advanced research solutions have helped them in appropriate decision-making and guidance for strategies to expand their business.
Contact Us:
Facts & Factors
A 2108, Sargam,
Nanded City,
Sinhagad Road,
Pune 411041, India
USA: +1-347-989-3985
Email: [email protected]
Web: https://www.fnfresearch.com
